We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

ACTN3 rs1815739: What Your Genotype Means for Muscle Performance

rs1815739
Trait
Strong evidenceGene: ACTN3

The ACTN3 rs1815739 variant, commonly known as R577X, is a genetic polymorphism that influences the production of the protein alpha-actinin-3 in fast-twitch muscle fibers. It is widely studied for its statistical associations with human athletic performance, particularly in power and sprint-oriented activities.

What each genotype means

C/CModerate attention

Functional alpha-actinin-3 production

This genotype results in the production of the alpha-actinin-3 protein in fast-twitch muscle fibers. Research suggests that individuals with this genotype may have a slight advantage in activities requiring explosive muscle power and strength.

This genotype is common globally, though its prevalence varies significantly across different ancestral populations.

C/TLower attention

Partial alpha-actinin-3 production

This heterozygous genotype allows for the production of alpha-actinin-3 protein, though at potentially lower levels than the CC genotype. It is the most frequently observed genotype in many global populations and is often associated with a balanced profile regarding muscle fiber performance.

This is the most common genotype observed in many populations worldwide.

T/TModerate attention

Alpha-actinin-3 deficiency

This genotype contains two copies of the premature stop codon, resulting in a complete deficiency of the alpha-actinin-3 protein in fast-twitch muscle fibers. While this deficiency is not a disease, some studies suggest it may be associated with reduced performance in elite power-based sports and potentially a higher relative prevalence in endurance-focused individuals.

Carried by approximately 20% of the global population, though frequencies vary by ancestry.

Understanding the rs1815739 Variant

The rs1815739 variant is a single nucleotide polymorphism (SNP) located within the ACTN3 gene on chromosome 11. This specific change involves a cytosine-to-thymine substitution at position 577. In genetic terms, the 'R' allele represents the functional version of the gene, while the 'X' allele contains a premature stop codon. This stop codon prevents the body from producing the full-length alpha-actinin-3 protein. Because humans inherit two copies of every gene—one from each parent—individuals can have different combinations of these alleles. These combinations determine whether an individual produces the protein in their fast-twitch muscle fibers, produces a reduced amount, or lacks it entirely. This variant is one of the most frequently researched markers in sports genomics due to its clear, measurable impact on protein expression in skeletal muscle tissue.

The Role of the ACTN3 Gene

The ACTN3 gene provides instructions for making alpha-actinin-3, a structural protein found exclusively in fast-twitch muscle fibers. These fibers are specialized for generating rapid, forceful contractions, which are essential for activities like sprinting, jumping, and weightlifting. When the gene functions normally, alpha-actinin-3 helps anchor the muscle's contractile machinery, providing stability during high-intensity movement. When an individual carries two copies of the 'X' allele, they do not produce this protein at all. Interestingly, research indicates that humans can function perfectly well without alpha-actinin-3, as the related protein alpha-actinin-2 can compensate for its absence. While the lack of alpha-actinin-3 is not considered a disease or a medical condition, it does alter the physiological profile of muscle fibers, which is why scientists have spent decades investigating how this shift influences physical performance and muscle power.

Research and Athletic Associations

The association between rs1815739 and athletic performance is a major topic in sports science. Numerous studies have observed that elite power and sprint athletes are more likely to carry the 'R' allele, which allows for the production of alpha-actinin-3. Conversely, the 'XX' genotype, which results in a complete deficiency of the protein, is often found at lower frequencies in elite sprint cohorts. However, it is critical to interpret these findings with nuance. While the variant is statistically associated with elite performance, it is not a 'gene for speed.' It accounts for only a small percentage of the variation in muscle strength among the general population. Many factors, including training, nutrition, psychological drive, and hundreds of other genetic variants, contribute to athletic success. The evidence is strong regarding the protein's role in muscle physiology, but the variant should be viewed as one small piece of a much larger, complex biological puzzle.

Practical Considerations for Consumers

If you are curious about your own genotype, it is important to understand what this information can and cannot do. Knowing your ACTN3 status does not predict your future as an athlete, nor does it provide a roadmap for a specific training regimen. Because the variant's influence on muscle function is relatively minor in the context of daily life, it is not a diagnostic tool for health or fitness. You cannot use this information to 'diagnose' your athletic potential or to justify skipping specific types of exercise. Instead, this information is best viewed as an educational insight into your biological makeup. If you are an athlete looking to optimize your performance, the most effective approach remains working with qualified coaches and trainers who focus on evidence-based training principles, recovery, and nutrition, rather than relying on a single genetic marker to dictate your goals.

How common is this variant?

The frequency of the X allele varies significantly by ancestry, with the XX genotype occurring in approximately 18% of European populations and up to 25-29% in some Japanese cohorts.

Frequently asked questions

Is the ACTN3 XX genotype a medical condition?

No, the XX genotype is not a medical condition or a disease. It is a common genetic variation that results in the absence of the alpha-actinin-3 protein, which is compensated for by other proteins in the muscle.

Can I use this test to pick the best sport for my child?

No. Athletic success is determined by a complex combination of genetics, environment, training, and personal interest. A single genetic variant cannot predict athletic talent or determine which sport a person will excel at.

Does the XX genotype mean I cannot build muscle?

Not at all. Individuals with the XX genotype are fully capable of building muscle, increasing strength, and improving fitness through resistance training. The variant may influence the efficiency of fast-twitch fibers, but it does not prevent muscle growth.

Why is the RX genotype the most common?

The distribution of genotypes is determined by evolutionary history and population genetics. The RX genotype is frequently observed because the X allele is common across many global populations, leading to a high prevalence of the heterozygous state.

Sources & further reading

Educational information only, last refreshed 10/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs1815739?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in ACTN3